Private Markets Are Recovering but the Old Playbook Isn't

What's New

Schroders Capital's Private Markets Investment Outlook for Q3 2026, subtitled Recovery Redefined, argues that the recovery arriving in private markets is not the one most portfolios were positioned for. Investment and exit activity improved in early 2026 by value rather than by volume, meaning a handful of large transactions are carrying the statistics while the broader deal count stays depressed. Fundraising is in its fifth consecutive year of contraction with only the first signals of a turn, following what Schroders describes as the longest trough on record since 2000. The house view is that resilience, not recovery timing, should organise portfolio construction, and that private markets only add resilience through selective and deliberately diversified allocations. Its clearest positioning call is that small and mid market buyouts entering at 8.4x EBITDA look structurally more attractive than large buyouts at 14.1x.

Why It Matters

A recovery concentrated in large deals and large managers rewards exactly the part of the market where entry valuations are least attractive, which sets up a mismatch between where capital is flowing and where returns are likely to come from. Schroders is also explicitly sceptical on direct lending concentrated in US software, at a time when that is the single most crowded exposure in private credit. For GPs the message is that scale advantages in fundraising are running ahead of scale advantages in returns, and that gap eventually closes. For LPs and their platforms, the implication is that headline market recovery data is a poor guide to portfolio positioning, because value weighted activity and volume weighted activity are telling different stories.

Big Picture Drivers

• The valuation gap is the core opportunity: Small and mid market buyouts entered at 8.4x EBITDA in Q1 2026 against 14.1x for large buyouts and 17.8x for the Russell 2000, a discount of roughly 40 percent to large cap peers and 55 percent to listed comparables.

• Smaller companies carry structural resilience: Over 90 percent of small buyout revenue is domestic and more than 80 percent of private equity investment sits in service businesses, which reduces trade exposure at a moment when geopolitics is repricing supply chains.

• The trough has been unusually long: Four years of depressed fundraising, deal and exit volumes since the 2021 peak represent the most severe slowdown since 2000, which is itself the argument that entry conditions now favour deployers.

• Continuation vehicles are structural, not cyclical: GP led continuation deal value rose to $109 billion in 2025 from $76 billion in 2024, with cyclical factors accounting for only 9 percent of volume versus 14 percent the prior year.

• Credit risk is not uniformly compensated: Schroders separates broadly robust private debt from concentrated US software direct lending, and prefers infrastructure debt, asset based finance and insurance linked securities as sources of return that do not share the same drivers.

• Late stage venture is flashing a warning: Series D and later valuations sit above 2021 peaks on AI driven demand, with AI absorbing 40 to 50 percent of venture investment, while biotech trades at historical lows.

By The Numbers

• 8.4x versus 14.1x EBITDA entry multiples for small and mid market against large buyouts in Q1 2026, the cleanest expression of where capital is not going.

• Fifth consecutive year of fundraising contraction, the longest recorded trough, with recovery signals appearing only now.

• $109 billion of GP led continuation deal value in 2025, up from $76 billion, forecast to exceed $300 billion within the coming decade.

• Two thirds of potential continuation transactions involve companies with enterprise value below $750 million, placing the opportunity in the lower middle market rather than in the headline megadeals.

• US and UK office prices corrected 30 to 40 percent, the basis for Schroders' view that real estate valuations have stabilised and transaction activity can resume despite high financing costs.

• 84 percent of surveyed investors cite diversification and 83 percent capital protection as top priorities, which explains the report's framing of resilience over return maximisation.

Key Trends to Watch

• Value led recovery masks volume weakness: Watch deal counts rather than deal value over the next four quarters. If volume does not follow value, the recovery remains a large deal phenomenon and mid market exits stay difficult.

• Continuation vehicles institutionalise in the lower middle market: With fees roughly 50 percent below typical transactions and liquidity arriving about a year sooner, the structure is becoming a default tool rather than a last resort.

• Direct lending concentration gets stress tested: US software heavy loan books are the specific exposure Schroders flags. Any deterioration in software revenue growth tests a thesis embedded across many portfolios simultaneously.

• Infrastructure shifts toward volatility monetisation: Preference is moving to operational assets with contracted revenue plus grid flexibility and storage that profit from price volatility rather than despite it.

• Insurance linked securities gain allocation share: As correlation between private and public assets proves higher than assumed, return streams driven by insured events rather than economic growth become genuinely scarce.

The Wrap

The useful discipline in this outlook is its refusal to treat improving aggregate numbers as evidence that the previous cycle's positioning will work again. A market recovering by value in large deals, while entry multiples in the middle market sit at a 40 percent discount, is telling allocators that the recovery and the opportunity are in different places. That requires segment level visibility that most portfolio reporting does not currently provide, since blended fund level returns will not reveal whether performance came from the crowded end or the cheap end. For technology providers, the requirement is analytics that resolve below the fund level to deal size, sector concentration and entry multiple, because that is where the next cycle's dispersion will be decided.